Commentary: Old Self vs. New Self
Implantation of deep brain stimulator (DBS) leads for Gilles de Tourette syndrome was first described by Visser-Vanderwalle et al., with a reported 70%–90% decrease in tic frequency.1 Since that time, several targets, including the basal/ganglia and striatum, have been described. The target remains...
Main Author: | |
---|---|
Format: | Electronic Article |
Language: | English |
Check availability: | HBZ Gateway |
Journals Online & Print: | |
Fernleihe: | Fernleihe für die Fachinformationsdienste |
Published: |
Cambridge Univ. Press
2016
|
In: |
Cambridge quarterly of healthcare ethics
Year: 2016, Volume: 25, Issue: 4, Pages: 751-753 |
Online Access: |
Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |